How have IHE shares performed in 2024?

iShares U.S. Pharmaceuticals ETF's stock was trading at $61.80 at the beginning of the year. Since then, IHE shares have increased by 1.9% and is now trading at $62.99. View the best growth stocks for 2024 here .

What does IHE invest in?

iShares U.S. Pharmaceuticals ETF is a equity fund issued by iShares. IHE focuses on health care investments and follows the Dow Jones U.S. Select Pharmaceuticals Index. The fund's investments total to approximately $653.02 million assets under management.

What stocks does iShares U.S. Pharmaceuticals ETF hold?

IHE invests in 38 holdings. Some of the stocks in their portfolio include Eli Lilly and Company (LLY) , Johnson & Johnson (JNJ) , Zoetis (ZTS) , Viatris (VTRS) , Merck & Co., Inc. (MRK) , Bristol-Myers Squibb (BMY) , Pfizer (PFE) , Royalty Pharma (RPRX) , Jazz Pharmaceuticals (JAZZ) and Catalent (CTLT) .

What is the management fee for iShares U.S. Pharmaceuticals ETF?

iShares U.S. Pharmaceuticals ETF's management fee is 0.39% and has no other recorded expenses or fee waivers. The net expense ratio for IHE is 0.39%.

When did iShares U.S. Pharmaceuticals ETF's stock split?

iShares U.S. Pharmaceuticals ETF shares split before market open on Thursday, March 7th 2024. The 3-1 split was announced on Thursday, March 7th 2024. The newly minted shares were payable to shareholders after the closing bell on Thursday, March 7th 2024. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

What other stocks do shareholders of iShares U.S. Pharmaceuticals ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares U.S. Pharmaceuticals ETF investors own include United Parcel Service (UPS) , CVS Health (CVS) , Genuine Parts (GPC) , Intel (INTC) , Kinder Morgan (KMI) , Wells Fargo & Company (WFC) , Archer-Daniels-Midland (ADM) , BP (BP) and Campbell Soup (CPB) .

Who are iShares U.S. Pharmaceuticals ETF's major shareholders?

iShares U.S. Pharmaceuticals ETF's stock is owned by a variety of retail and institutional investors. Top institutional investors include Massachusetts Wealth Management (0.72%), Wealthcare Advisory Partners LLC (0.19%) and Matthew Goff Investment Advisor LLC (0.18%).

How do I buy shares of iShares U.S. Pharmaceuticals ETF?

Shares of IHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSEARCA:IHE

iShares U.S. Pharmaceuticals ETF (IHE) Price, Holdings, & News

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free IHE Stock Alerts

$62.99

-0.11 (-0.17%)

(As of 04/19/2024 ET)

Compare

Today's Range: $62.78
▼
$63.21
50-Day Range: $62.99
▼
$69.55
52-Week Range: $55.36
▼
$69.56

Volume: 67,633 shs
Average Volume: 73,144 shs
Market Capitalization: $129.13 million

Assets Under Management: $653.02 million
Dividend Yield: 5.92%
Net Expense Ratio: 0.39%

Stock Analysis Chart Headlines Holdings Ownership Ratings

Get iShares U.S. Pharmaceuticals ETF alerts:

About iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors.

IHE Stock Price History

30 days | 90 days | 365 days | Advanced Chart

IHE ETF News Headlines

April 17, 2024 | finance.yahoo.com

JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus

April 10, 2024 | msn.com

This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 4, 2024 | msn.com

Unified Action: Biden and Sanders Target Pharma Pricing

March 18, 2024 | seekingalpha.com

IHI: Technological Advances Will Continue Carrying This High-Performing Medical ETF

February 14, 2024 | msn.com

Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

February 7, 2024 | finance.yahoo.com

ETFs to Buy as Mounjaro Powers Eli Lilly's Q4 Earnings Beat

January 31, 2024 | uk.investing.com

iShares U.S. Pharmaceuticals ETF (IHE)

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

January 31, 2024 | seekingalpha.com

EIS: A Strong Recovery Play

See More Headlines

Receive IHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer: iShares
Fund Name: iShares U.S. Pharmaceuticals ETF
Tax Classification: Regulated Investment Company
Stock Exchange: NYSEARCA
Current Symbol: NYSEARCA:IHE
Inception Date: 5/1/2006
Fund Manager: Diane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
Web: www.iShares.com
Phone: N/A

Fund Focus

Asset Class: Equity
Benchmark: Dow Jones U.S. Select Pharmaceuticals Index
Category: Sector
Focus: Health Care
Development Level: Developed Markets
Region: North America
Number of Holdings: 38

Fund Statistics

Assets Under Management: $653.02 million
Average Daily Volume: $93,352.30
Discount/Premium: 0.01%

Administrator, Advisor and Custodian

Administrator: Citibank, N.A.
Advisor: BlackRock Fund Advisors
Custodian: Citibank, N.A.
Distributor: BlackRock Investments, LLC
Transfer Agent: Citibank, N.A.
Trustee: N/A
Lead Market Maker: Latour Trading

Options

Optionable: Optionable
Options Volume: 6
Put Options: 16
Call Options: 6
Short Interest: 86,600 shs

Miscellaneous

Outstanding Shares: 2,050,000
Beta: 0.70
Creation Unit: 50,000
Creation Fee: $306.00

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

iShares U.S. Pharmaceuticals ETF Expenses

Type	IHE	Health Care ETFs	Equity ETFs	NYSEARCA ETFs	All ETFs
Management Fee	0.39%	0.56%	0.54%	0.50%	0.51%
Other Expenses	0.00%	0.40%	0.54%	0.64%	0.58%
Total Expense	0.39%	0.72%	0.70%	0.74%	0.70%
Fee Waiver	0.00%	-0.53%	-0.55%	-0.68%	-0.57%
Net Expense	0.39%	0.60%	0.60%	0.58%	0.58%

iShares U.S. Pharmaceuticals ETF (IHE) Holdings & Exposure

Top 10 IHE Holdings

IHE Sector Exposure

IHE Industry Exposure

Full Holdings Details

Key Executives

George G. C. Parker Ph.D. (Age 78)
Independent Chairman of the Board of Trustees
Michael Arthur Latham (Age 51)
President, Trustee
Jack Gee (Age 57)
Chief Financial Officer, Treasurer
Geoffrey D. Flynn
Chief Operating Officer, Executive Vice President
Amy Schioldager (Age 56)
Executive Vice President
Ira P. Shapiro (Age 52)
Vice President, Chief Legal Officer
Matt Tucker
Vice President
Eilleen M. Clavere (Age 61)
Secretary
Cecilia H. Herbert (Age 68)
Independent Trustee
Charles A. Hurty (Age 73)
Independent Trustee

Similar ETFs

Institutional Ownership

View All Institutional Transactions

IHE ETF - Frequently Asked Questions

How have IHE shares performed in 2024?: iShares U.S. Pharmaceuticals ETF's stock was trading at $61.80 at the beginning of the year. Since then, IHE shares have increased by 1.9% and is now trading at $62.99.
View the best growth stocks for 2024 here.
What does IHE invest in?: iShares U.S. Pharmaceuticals ETF is a equity fund issued by iShares. IHE focuses on health care investments and follows the Dow Jones U.S. Select Pharmaceuticals Index. The fund's investments total to approximately $653.02 million assets under management.
What stocks does iShares U.S. Pharmaceuticals ETF hold?: IHE invests in 38 holdings. Some of the stocks in their portfolio include Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), Zoetis (ZTS), Viatris (VTRS), Merck & Co., Inc. (MRK), Bristol-Myers Squibb (BMY), Pfizer (PFE), Royalty Pharma (RPRX), Jazz Pharmaceuticals (JAZZ) and Catalent (CTLT).
What is the management fee for iShares U.S. Pharmaceuticals ETF?: iShares U.S. Pharmaceuticals ETF's management fee is 0.39% and has no other recorded expenses or fee waivers. The net expense ratio for IHE is 0.39%.

When did iShares U.S. Pharmaceuticals ETF's stock split?: iShares U.S. Pharmaceuticals ETF shares split before market open on Thursday, March 7th 2024. The 3-1 split was announced on Thursday, March 7th 2024. The newly minted shares were payable to shareholders after the closing bell on Thursday, March 7th 2024. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.
What other stocks do shareholders of iShares U.S. Pharmaceuticals ETF own?: Based on aggregate information from My MarketBeat watchlists, some companies that other iShares U.S. Pharmaceuticals ETF investors own include United Parcel Service (UPS), CVS Health (CVS), Genuine Parts (GPC), Intel (INTC), Kinder Morgan (KMI), Wells Fargo & Company (WFC), Archer-Daniels-Midland (ADM), BP (BP) and Campbell Soup (CPB).
Who are iShares U.S. Pharmaceuticals ETF's major shareholders?: iShares U.S. Pharmaceuticals ETF's stock is owned by a variety of retail and institutional investors. Top institutional investors include Massachusetts Wealth Management (0.72%), Wealthcare Advisory Partners LLC (0.19%) and Matthew Goff Investment Advisor LLC (0.18%).
How do I buy shares of iShares U.S. Pharmaceuticals ETF?: Shares of IHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:IHE) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial